ARCHIVES

51% Control Rate Achieved In Phase II Trial of Elderly Patients

This article is from The Cancer Letter archive.

Vol. 36 No. 3 | March 29, 2013

Download PDF Visit The Full Archive

Related Articles

Brigham & Women’s Suspends Controversial Morcellation Study As Apparent “Difference of Opinion” with FDA Comes to Light

November 26, 2014

Acupuncture Can Relieve Side Effects of Hormone Treatment

April 29, 2011

Judge Declines To Issue Injunction To Stop Amgen’s “Bundling.”

December 1, 2006

RFPs Available

May 5, 2000

In Brief: Kennedy Drops Health Care Institute Plan Senate Approves Dole Amendment On Patents

August 18, 1978

Charges Against CC Probed; Most Found Invalid

March 31, 1978